If your insurance denies coverage through Ro, you could be left paying upwards of $1,000+ per month at the pharmacy
Aug 29 2023;82(9):833-955
Several states (e.g., North Carolina, California, Connecticut, Rhode Island, Michigan) have paused or proposed ending Medicaid coverage for GLP1 drugs for weight loss due to escalating costs, while continuing coverage for diabetes or cardiovascular risk indications
It does not prescribe or dispense medications itself, but facilitates access through a verified provider and pharmacy network
Whilst there is no absolute contraindication, the medication's gastrointestinal effectsincluding delayed gastric emptying and common side effects such as nausea and diarrhoeamay complicate Crohn's disease management